SCHEMBL7991608

SCHEMBL7991608

CN(Cc1nc(=O)c2c(ncn2CCc2ccccc2)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 7/20 0.47
P2RX3 P56373 1/20 0.40
HTR2C P28335 2/20 0.39
SLC6A4 P31645 2/20 0.39
CACNA1G O43497 1/20 0.38
CACNA1B Q00975 1/20 0.38
CACNA1C Q13936 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PARN O95453 2/20 0.37
MCL1 Q07820 1/20 0.37
GLS O94925 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985316 0.95 CNOT7 (0.48) CNOT7P2RX3HTR2CSLC6A4CACNA1G
SCHEMBL7985460 0.91 CNOT7 (0.45) CNOT7HTR2CSLC6A4CACNA1GCACNA1B
SCHEMBL7991611 0.85 HPGD (0.42) CNOT7P2RX3HTR2CSLC6A4CACNA1G
SCHEMBL7988921 0.84 CNOT7 (0.44) CNOT7HTR2CSLC6A4ALDH1A1PARN
SCHEMBL7975225 0.83 CACNA1G (0.40) P2RX3HTR2CSLC6A4CACNA1GCACNA1B
SCHEMBL7987945 0.83 CACNA1G (0.39) CNOT7HTR2CSLC6A4CACNA1GCACNA1B
SCHEMBL7988124 0.82 SMN1; SMN2 (0.41) CNOT7HTR2CSLC6A4CACNA1GCACNA1B
SCHEMBL7974030 0.82 CNOT7 (0.42) CNOT7HTR2CSLC6A4ALDH1A1PARN
SCHEMBL7974301 0.82 CACNA1G (0.40) CNOT7HTR2CSLC6A4CACNA1GCACNA1B
SCHEMBL7992288 0.82 ABCC8 (0.41) CNOT7HTR2CSLC6A4CACNA1GCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed